ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $940,510 | -9.9% | 34,654 | +2.0% | 0.01% | -10.0% |
| Q2 2023 | $1,044,269 | -7.7% | 33,971 | +8.1% | 0.01% | -16.7% |
| Q1 2023 | $1,131,918 | -7.5% | 31,416 | +1.4% | 0.01% | -7.7% |
| Q4 2022 | $1,224,132 | -11.6% | 30,975 | -10.1% | 0.01% | -18.8% |
| Q3 2022 | $1,384,000 | -18.6% | 34,446 | -14.8% | 0.02% | 0.0% |
| Q2 2022 | $1,700,000 | -17.8% | 40,440 | -23.8% | 0.02% | +23.1% |
| Q1 2022 | $2,067,000 | -13.5% | 53,044 | -11.5% | 0.01% | 0.0% |
| Q4 2021 | $2,389,000 | +102.6% | 59,946 | +83.8% | 0.01% | +85.7% |
| Q3 2021 | $1,179,000 | -11.1% | 32,621 | +0.8% | 0.01% | -12.5% |
| Q2 2021 | $1,326,000 | +6.2% | 32,356 | +13.0% | 0.01% | -11.1% |
| Q1 2021 | $1,249,000 | +29.8% | 28,623 | +49.0% | 0.01% | +28.6% |
| Q4 2020 | $962,000 | – | 19,212 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |